Currently, some studies have linked MIF concentration to particular SSc presentations, such as pulmonary arterial hypertension (PAH), impaired lung function, and ACE inhibitor usage, although not all studies have confirmed this [96]. The gene discussed is MIF; the disease is pulmonary arterial hypertension.